The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,789.50
Bid: 1,789.00
Ask: 1,789.50
Change: 11.50 (0.65%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,790.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Footsie advances as Barclays rebounds

Mon, 02nd Jul 2012 11:41

- Better-than-expected manufacturing data from Asia- Eurozone jobless rate at all-time high- UK manufacturing PMI beats forecastsLondon's blue-chip index held on to gains on Monday morning with Barclays leading the risers as it continues to rebound after last week's sharp falls.Economic data from Asia helped to lift sentiment early on: China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9; while Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged reading. The Eurozone's unemployment rate rose to 11.1% in May, in line with estimates and the highest since the creation of the Eurozone, according to the latest data from the region's statistics office, Eurostat. In domestic news, UK manufacturing PMI rose from 45.9 to 48.6 in June, well ahead of expectations of 46.5. However, with the sector still contracting (readings below 50 points), the pressure is mounting for the Bank of England to ramp up its asset purchase programme on Thursday when it announces its July policy decision.FTSE 100: Barclays rebounds after recent sell-offBarclays, the bank which last week was given a £290m fine for manipulating interbank lending rates, was a high riser today after revealing that its Chairman Macrus Agius has resigned. After numerous calls for CEO Bob Diamond to follow in Agius's footsteps, Investec analyst Ian Gordon said this morning that investors should "back Bob" and take advantage of the stock's recent underperformance.Royal Bank of Scotland (RBS) was flat after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked several traders last year over the alleged manipulation of LIBOR. Insurance group Aviva advanced after announcing that Lord Colin Sharman has retired as Chairman and has been replaced by John McFarlane.Pharmaceuticals giant GlaxoSmithKline rose after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012. Sector peer AstraZeneca was flat despite saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers. Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team. FTSE 250: SOCO jumps over 8%Oil and gas group SOCO International surged after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. Insurance group Catlin fell after Jefferies downgraded the stock as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible." FTSE 100 - RisersBarclays (BARC) 168.65p +3.56%Aviva (AV.) 281.90p +3.41%Petrofac Ltd. (PFC) 1,427.00p +2.81%Weir Group (WEIR) 1,571.00p +2.68%Whitbread (WTB) 2,071.00p +2.12%BP (BP.) 430.05p +1.92%Rio Tinto (RIO) 3,077.00p +1.92%Amec (AMEC) 1,021.00p +1.90%Prudential (PRU) 751.00p +1.76%WPP (WPP) 786.50p +1.75%FTSE 100 - FallersShire Plc (SHP) 1,782.00p -2.73%British Sky Broadcasting Group (BSY) 688.00p -1.22%Smith & Nephew (SN.) 630.00p -1.18%Vodafone Group (VOD) 177.45p -1.00%Admiral Group (ADM) 1,183.00p -0.76%Morrison (Wm) Supermarkets (MRW) 264.40p -0.64%Pearson (PSON) 1,259.00p -0.55%AstraZeneca (AZN) 2,838.00p -0.53%Next (NXT) 3,184.00p -0.47%Capital Shopping Centres Group (CSCG) 320.90p -0.34%FTSE 250 - RisersSoco International (SIA) 310.90p +7.43%Imagination Technologies Group (IMG) 499.50p +7.05%Fenner (FENR) 380.80p +5.40%Aquarius Platinum Ltd. (AQP) 48.11p +5.37%Kenmare Resources (KMR) 41.50p +5.06%Travis Perkins (TPK) 1,019.00p +5.00%Ashtead Group (AHT) 271.40p +4.42%Shanks Group (SKS) 79.25p +3.80%Smith (DS) (SMDS) 152.70p +3.60%Oxford Instruments (OXIG) 1,269.00p +3.42%FTSE 250 - FallersAvocet Mining (AVM) 81.00p -10.05%Ocado Group (OCDO) 75.40p -2.96%Halfords Group (HFD) 223.60p -2.44%Euromoney Institutional Investor (ERM) 731.00p -2.08%Spirit Pub Company (SPRT) 49.75p -1.97%Debenhams (DEB) 85.25p -1.45%Catlin Group Ltd. (CGL) 419.80p -1.34%Perform Group (PER) 395.00p -1.25%Ruspetro (RPO) 133.50p -1.18%Home Retail Group (HOME) 83.65p -1.18%FTSE TechMARK - RisersAsterand (ATD) 1.05p +13.51%Phytopharm (PYM) 6.20p +5.53%Timeweave (TMW) 21.00p +5.00%Hiwave Technologies (HIW) 1.50p +3.45%Gresham Computing (GHT) 61.00p +2.95%Electronic Data Processing (EDP) 43.50p +2.35%Oxford Biomedica (OXB) 2.40p +2.13%Kofax (KFX) 256.25p +2.09%NCC Group (NCC) 815.00p +2.07%Sepura (SEPU) 68.25p +1.87%FTSE TechMARK - FallersBATM Advanced Communications Ltd. (BVC) 14.00p -4.27%Emblaze Ltd. (BLZ) 51.60p -3.55%AEA Technology Group (AAT) 0.20p -2.44%Vectura Group (VEC) 76.00p -0.98%Skyepharma (SKP) 78.25p -0.95%Phoenix IT Group (PNX) 180.00p -0.83%Microgen (MCGN) 139.00p -0.71%Ricardo (RCDO) 340.00p -0.58%Psion (PON) 87.00p -0.57%Consort Medical (CSRT) 700.00p -0.57%
More News
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.